Dana-Farber President and Chief Executive Officer, Scholar, Scientist
Laurie H. Glimcher, MD, president and chief executive officer of Dana-Farber, is also chief executive officer of Dana-Farber/Partners CancerCare, director of Dana-Farber/Harvard Cancer Center, and a trustee
of Dana-Farber/Children's Hospital Cancer Care. Dr. Glimcher helped develop Vice President Joe Biden's Moonshot initiative, and witnessed the 21st Century Cures Bill being signed into law.
Dr. Glimcher has served as the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medical College, and as Cornell's Provost for Medical Affairs. She has served as the Irene Heinz Given Professor of Immunology at the Harvard School
of Public Health, where she directed the Division of Biological Sciences. She was also Professor of Medicine at Harvard Medical School, where she headed one of the world's premier immunology programs.
Dr. Glimcher is the recipient of numerous awards and honors, including the Soma Weiss Award for Undergraduate Research, the Distinguished Young Investigator Award from the American College of Rheumatology, the Leukemia Society's Stohlman Memorial Scholar Award, the Arthritis Foundation's Lee S. Howley Award, the FASEB Excellence in Science Award, the American Society of Clinical Investigation Investigator Award, the Klemperer Award, the AAUW Senior Scholar Award, the Huang Meritorious Career Award, the AAI Excellence in Mentoring Award, the Dean's Award for Leadership in the Advancement of Women Faculty, the American College of Rheumatology Distinguished Investigator Award, the Ernst Bertner Award, the William Coley Award, The Vanderbilt Prize, among others. Glimcher recently received the Indiana University School of Medicine Steven C. Beering Award for outstanding research contributions to advancement of biomedical or clinical science, the L'Oréal-UNESCO Award for Women in Science, the 2017 George M. Kober Medal, and the 2017 Award for Distinguished Research in the Biomedical Sciences from the AAMC.
Dr. Glimcher is a Fellow of the American Academy of Arts and Sciences, and a member of the National Academy of Medicine of the National Academy of Sciences. She is the former President of the American Association of Immunologists. She is a member of the American Asthma Foundation and Cancer Research Institute Scientific Advisory Boards and served on the Burroughs-Wellcome Fund and HHMI Scientific Advisory Boards. She serves on the Scientific Steering Committee for the Parker Institute for Cancer Immunotherapy and the Scientific Advisory Board for Repare Therapeutics. She is the co-founder of Quest Therapeutics for which she also serves as chair of the Scientific Advisory Board. Dr. Glimcher is on the Corporate Board of Directors of the Waters Corporation and GlaxoSmithKline plc.
A magna cum laude graduate of Radcliffe College with an MD degree cum laude from Harvard Medical School, Dr. Glimcher is the Richard and Susan Smith Professor of Medicine and a professor of Immunobiology at Harvard Medical School.